Zoetis announced today the availability of STARTECTTM, a dual active oral anthelmintic solution for sheep.
Now Available from Zoetis Canada
FOR IMMEDIATE RELEASE
January 22nd, 2018
France Lanthier Zoetis
Kirkland, QC, January 22nd, 2018 — Zoetis announced today the availability of STARTECTTM, a dual active oral anthelmintic solution for sheep. STARTECT contains 1.0 mg abamectin and 10 mg derquantel and is a highly effective, short-acting oral sheep drench designed to optimize flock productivity1-5, and is the first new class of drench to be approved in combination – a combination developed to be effective against parasite resistance. “Parasite resistance has become an important issue in sheep flocks in Canada leading to a loss in productivity and even death. The introduction of STARTECT will have a major impact on reducing this management concern.” comments Dr. Melanie Wowk, Manager Veterinary Services – Cattle, Equine, Genetics Product Support.
STARTECT treats and controls a broad range of adult and immature worms, including the “barber pole worm”, Haemonchus contortus, and other important gastro intestinal nematode parasites such as Teladorsagia and Trichostrongylus. Startect has also demonstrated high efficacy (greater than 95%) against certain worms known to be resistant to other dewormers.
“Zoetis, along with veterinarians and the Veterinary Directorate branch of Health Canada acknowledge that the use of STARTECT in flocks should be combined with a sustainable Integrated Parasite Management program in order to preserve efficacy. In order to help producers manage resistance, all parties collaborated to develop a Customer Information Sheet that is included with every unit of STARTECT” comments Toni Bothwell, Director of
Regulatory Affairs and Pharmacovigilence at Zoetis Canada Inc. “Zoetis is proud to support the Canadian sheep industry and to build collaborative relationships with multiple industry stakeholders”.
A prescription from a licensed veterinarian is needed to obtain STARTECT. For more information about STARTECT and its role in flock health, contact your veterinarian and your Zoetis Territory Manager.
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
For more information, visit www.Zoetis.ca
1. Little PR, Hodge A, Maeder SJ et al. Efficacy of a combined oral formulation of derquantel-abamectin against the adult and larval stages of nematodes in sheep, including anthelmintic resistant strains. Veterinary Parasitology 2011; 181: 180–93. 2. Little PR, Hodge A, Watson TG et al. Field efficacy and safety of an oral formulation of the novel combination anthelmintic, derquantel-abamectin in sheep in New Zealand, NZ Vet J 2010; 58(3):121–9. 3. Geurden T, Hodge A, Noe L etal. The efficacy of a combined oral formulation of derquantel-abamectin against anthelmintic resistant gastrointestinal nematodes of sheep in the UK, Vet Parasitol 2012; 189: 308–
16. 4. Bartrum D, Little P, Geurden T et al. Efficacy of an oral formulation of derquantel–abamectin in sheep experimentally infected with macrocyclic lactone resistant Teladorsagia circumcincta, Proceedings of the 8th International Sheep Veterinary Congress 2013, Rotorua, New Zealand. 5. Startect Product Label, 2017, Zoetis